|HUM-MOLGEN -> Events -> Meetings and Conferences|
|Antibody Production and Downstream Processing|
|September 25, 2001|
IBC USA Conferences, Inc., Paradise Point Resort * San Diego, CA
February 13-15, 2002
IBC’s 8th International Antibody Production and Downstream Processing provides the most comprehensive update on antibody manufacturing capacity, technologies and economics. This conference gives the answers to these questions from the leading antibody manufacturers, in addition to perspectives of newer companies:
When will there be enough manufacturing capcity for the antibody-based therapeutics in the pipeline?
What can you do to make your bioprocess compliant with international regulatory requirements?
How will the industry be able to develop cost-competitive drugs?
When will novel expression systems be accepted?
Why does glycosylation affect antibody structure, function and activity?
Gain news from over 40 industry suppliers in the expanded exhibit hall, and enjoy ample networking occasions including receptions in the exhibit hall and hospitality suites. Register today!
|Organized by:||IBC USA Conferences, Inc.|
|Invited Speakers:||Keynote Presenters:
Manufacturing Capacity for Antibody Drug Candidates:
The Outsource of Build Decision
- Wolfgang Berthold, Ph.D., Senior Vice President, Biopharmaceutical Sciences, IDEC Pharmaceuticals Corporation
Therapeutic Antibody Expression Technology: Current Opinions
- Steven Chamow, Ph.D., Vice President, Process Sciences, Abgenix, Inc.
|Deadline for Abstracts:||-|
|Registration:||Five Easy Ways to Register!
Phone (508) 616-5550
Fax (508) 616-5522
IBC USA Conferences, Inc.
One Research Drive, Suite 400A
P.O. Box 5195
Westborough, MA 01581-5195
|Posted by:||James G. Prudhomme|